Literature DB >> 22266187

MicroRNA-449a acts as a tumor suppressor in human bladder cancer through the regulation of pocket proteins.

Hong Chen1, Yi-wei Lin, Ye-qing Mao, Jian Wu, Yun-fu Liu, Xiang-yi Zheng, Li-ping Xie.   

Abstract

Frequent downregulation of microRNA-449a (miR-449a) was detected in 14 human bladder cancer tissues. The restoration of miR-449a inhibited cell growth and induced G1-phase arrest in T24 and 5637 human bladder cancer cells. CDK6 and CDC25a were downregulated after miR-449a treatment, resulting in the functional accumulation of the pocket proteins Rb and p130. The growth of T24 tumor xenografts was suppressed by exogenous miR-449a, and the nuclear proliferation antigen Ki-67 was downregulated in miR-449a-treated tumors. These results suggest a tumor-suppressive role for miR-449a in human bladder cancer.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22266187     DOI: 10.1016/j.canlet.2012.01.027

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  45 in total

1.  MiR-449a regulates autophagy to inhibit silica-induced pulmonary fibrosis through targeting Bcl2.

Authors:  Ruhui Han; Xiaoming Ji; Rong Rong; Yan Li; Wenxi Yao; Jiali Yuan; Qiuyun Wu; Jingjin Yang; Weiwen Yan; Lei Han; Baoli Zhu; Chunhui Ni
Journal:  J Mol Med (Berl)       Date:  2016-06-28       Impact factor: 4.599

2.  miRNA-449a is downregulated in osteosarcoma and promotes cell apoptosis by targeting BCL2.

Authors:  Jie Chen; Jinsong Zhou; Xin Chen; Baohui Yang; Dong Wang; Pinglin Yang; Xijing He; Haopeng Li
Journal:  Tumour Biol       Date:  2015-05-23

Review 3.  Targeted therapies in bladder cancer: an overview of in vivo research.

Authors:  Kim E M van Kessel; Tahlita C M Zuiverloon; Arnout R Alberts; Joost L Boormans; Ellen C Zwarthoff
Journal:  Nat Rev Urol       Date:  2015-09-22       Impact factor: 14.432

4.  Hsa-miR-449a genetic variant is associated with risk of gastric cancer in a Chinese population.

Authors:  Jian Shi; Yangchen Liu; Jun Liu; Juan Zhou
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

5.  Expression of miR-149-3p inhibits proliferation, migration, and invasion of bladder cancer by targeting S100A4.

Authors:  Dengke Yang; Guang Du; An Xu; Xuetao Xi; Dong Li
Journal:  Am J Cancer Res       Date:  2017-11-01       Impact factor: 6.166

Review 6.  Aberrant expression of microRNAs in bladder cancer.

Authors:  Hirofumi Yoshino; Naohiko Seki; Toshihiko Itesako; Takeshi Chiyomaru; Masayuki Nakagawa; Hideki Enokida
Journal:  Nat Rev Urol       Date:  2013-05-28       Impact factor: 14.432

7.  Changes in microRNA and mRNA expression with differentiation of human bronchial epithelial cells.

Authors:  Asuncion Martinez-Anton; Milena Sokolowska; Steven Kern; A Sally Davis; Sara Alsaaty; Jeffery K Taubenberger; Junfeng Sun; Rongman Cai; Robert L Danner; Michael Eberlein; Carolea Logun; James H Shelhamer
Journal:  Am J Respir Cell Mol Biol       Date:  2013-09       Impact factor: 6.914

Review 8.  Noncoding RNAs in DNA repair and genome integrity.

Authors:  Guohui Wan; Yunhua Liu; Cecil Han; Xinna Zhang; Xiongbin Lu
Journal:  Antioxid Redox Signal       Date:  2013-09-18       Impact factor: 8.401

9.  miR-449a contributes to glucocorticoid-induced CRF-R1 downregulation in the pituitary during stress.

Authors:  Takahiro Nemoto; Asuka Mano; Tamotsu Shibasaki
Journal:  Mol Endocrinol       Date:  2013-07-26

Review 10.  The evolving understanding of microRNA in bladder cancer.

Authors:  Elizabeth A Guancial; Joaquim Bellmunt; Shuyuan Yeh; Jonathan E Rosenberg; David M Berman
Journal:  Urol Oncol       Date:  2013-08-02       Impact factor: 3.498

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.